The Efficacy of Surgical Site Treatment With Ropivacaine in Laparoscopic Surgery

NCT ID: NCT02826876

Last Updated: 2016-07-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2017-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Using local analgesia in laparoscopic surgery in order to reduce pain and to reduce the use of narcotic drugs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

At the end of laparoscopic surgery the investigators will spray ropivacaine in the surgical site; and later the investigators will monitor pain intensity and use of analgesic drugs

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ropivacaine

Topical use of Ropivacaine

Group Type PLACEBO_COMPARATOR

Topical use

Intervention Type DRUG

Topical use of Ropivacaine in laparoscopic surgery

laparoscopic repair of inguinal hernia

Intervention Type OTHER

intra-operative treatment with ropivacaine Vs placebo in laparoscopic repair of inguinal hernia

laparoscopic bariatric surgery

Intervention Type OTHER

intra-operative treatment with ropivacaine Vs placebo in laparoscopic bariatric surgery

Placebo

Topical use of placebo

Group Type PLACEBO_COMPARATOR

Topical use

Intervention Type DRUG

Topical use of Ropivacaine in laparoscopic surgery

laparoscopic repair of inguinal hernia

Intervention Type OTHER

intra-operative treatment with ropivacaine Vs placebo in laparoscopic repair of inguinal hernia

laparoscopic bariatric surgery

Intervention Type OTHER

intra-operative treatment with ropivacaine Vs placebo in laparoscopic bariatric surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Topical use

Topical use of Ropivacaine in laparoscopic surgery

Intervention Type DRUG

laparoscopic repair of inguinal hernia

intra-operative treatment with ropivacaine Vs placebo in laparoscopic repair of inguinal hernia

Intervention Type OTHER

laparoscopic bariatric surgery

intra-operative treatment with ropivacaine Vs placebo in laparoscopic bariatric surgery

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Ropivacaine Placebo

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Laparoscopic bariatric surgery
* Laparoscopic inguinal hernia surgery

Exclusion Criteria

* Cardiac arrythmias
* Active ischemic heart disease
* pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Western Galilee Hospital-Nahariya

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Farraj Moaad

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Moaad H Farraj, Dr

Role: PRINCIPAL_INVESTIGATOR

Galilee Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Naharia Medical Center

Nahariya, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Moaad H Farraj, Dr

Role: CONTACT

0507887996 ext. 972

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0196-15-NHR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Herniorrhaphy for Postoperative Pain
NCT05813847 RECRUITING PHASE3